Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
4.130
-0.030 (-0.72%)
Nov 5, 2025, 9:32 AM EST - Market open
Eledon Pharmaceuticals Market Cap
Eledon Pharmaceuticals has a market cap or net worth of $247.31 million as of November 5, 2025. Its market cap has increased by 101.22% in one year.
Market Cap
247.31M
Enterprise Value
142.34M
1-Year Change
101.22%
Ranking
Category
Stock Price
$4.13
Market Cap Chart
Since May 11, 2017, Eledon Pharmaceuticals's market cap has increased from $44.66M to $247.31M, an increase of 453.77%. That is a compound annual growth rate of 22.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 249.11M | 1.21% |
| Dec 31, 2024 | 246.13M | 465.07% |
| Dec 29, 2023 | 43.56M | 38.87% |
| Dec 30, 2022 | 31.37M | -50.29% |
| Dec 31, 2021 | 63.09M | -72.98% |
| Dec 31, 2020 | 233.47M | 3,004.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 807.78B |
| Johnson & Johnson | 449.12B |
| AbbVie | 381.26B |
| UnitedHealth Group | 299.90B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 218.23B |
| Novo Nordisk | 215.64B |